Head-to-head · free
O'Reilly Automotive vs The Precision Peptide Company
ORLY vs PNGAF — return on capital, cash generation, margins and balance sheet side by side.
ORLY
0 / 0
measures where ORLY leads
PNGAF
0 / 0
measures where PNGAF leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | ORLY · FY2025 | PNGAF |
|---|---|---|
| Revenue | $17.8B | — |
| Net income | $2.5B | — |
| Revenue growth (yearly, multi-year) | 54.9% | — |
| Free cash flow | $1.6B | — |
| Free cash flow margin | 9.0% | — |
| Net cash / (debt) | — | — |
| ROIC | 38.0% | — |
| Return on equity | — | — |
| Gross margin | 51.6% | — |
| Operating margin | 19.5% | — |
| Net debt / EBITDA | 1.47x | — |
Figures are as reported by each company; latest fiscal year shown.
Where O'Reilly Automotive's cash went (FY2025)
- Capital spending
- $1.2B
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free